Kineret

Links shared publicly online about this topic

Benefits of long-term Kineret therapy in people with NOMID

news-medical.net — “A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on February 13, 2012 at 11:00 am By:

Arthritis_News News-Medical.Net Health News

Arthritis News: Benefits of long-term Kineret therapy in people with NOMID: A new study shows that Kineret (anak... http://t.co/KJ7o7RyD

3 months ago...

Efficacy of Anti-Interleukin-1 Receptor Antagonist Anakinra (Kineret®) in a Case of Refractory Sweet--™s Syndrome

content.karger.com — “Sweet--™s syndrome is a neutrophilic dermatosis characterized by fever, an elevated neutrophil count, and painful erythematous cutaneous lesions. Histopathological analysis reveals a neutrophilic dermal infiltrate. Systemic corticosteroid therapy remains the mainstay of treatment. We report the case of a 66-year-old male patient who had a 5-year history of Sweet--™s syndrome refractory to various conventional treatments. Anti-interleukin-1 receptor antagonist anakinra was initiated aView full resource at content.karger.com

  • View Related
  • Share

Most Recently Shared on April 4, 2011 at 9:42 pm By:

Dermatology_OW Dermatology Wisdom OW Health

Efficacy of Anti-Interleukin-1 Receptor Antagonist Anakinra (Kineret®) in a Case of Refractory Sweet’s Syndro... http://bit.ly/fntHzM

1 year ago...

Drug halts organ damage in inflammatory genetic disorder, study suggests

sciencedaily.com — “A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease. This rare and debilitating genetic disorder causes persistent inflammation and ongoing tissue damage.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on February 11, 2012 at 6:35 pm By:

ArthritisUpdate Arthritis News Health News

Science Daily: Drug halts organ damage in inflammatory genetic disorder, study suggests http://t.co/qLbwP7km Full http://t.co/xwlHZeT9

3 months ago...

Rheumatoid Arthritis - Biologic Medications for Rheumatoid Arthritis: Cimzia vs. Simponi

healthcentral.com — “With nine biologic medications available to treat rheumatoid arthritis, it can be difficult knowing which to choose and how they compare.  Read my previous...View full resource at healthcentral.com

  • View Related
  • Share

Most Recently Shared on May 3, 2010 at 2:34 pm By:

LisaEmrich Lisa Emrich Patient Expert

Biologic Medications for RA: Cimzia vs. Simponi - With nine biologic medications available to treat rheumatoid arth... http://ow.ly/17fDbf

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390